Cargando…
Natural Killer Anti-Tumor Activity Can Be Achieved by In Vitro Incubation With Heat-Killed BCG
Natural Killer cell receptors allow this heterogeneous immune population to efficiently fight both tumors and infection, so their use as immunotherapy agents is an active field of research. Cytokine activation, particularly by myeloid cell-derived IL15, can induce potent NK anti-tumor responses. Whi...
Autores principales: | Esteso, Gloria, Aguiló, Nacho, Julián, Esther, Ashiru, Omodele, Ho, Mei. M., Martín, Carlos, Valés-Gómez, Mar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940681/ https://www.ncbi.nlm.nih.gov/pubmed/33708215 http://dx.doi.org/10.3389/fimmu.2021.622995 |
Ejemplares similares
-
BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and γδ T-cells that can be further expanded in vitro
por: Esteso, Gloria, et al.
Publicado: (2022) -
Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung
por: Moreo, Eduardo, et al.
Publicado: (2023) -
BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine
por: Ashiru, Omodele, et al.
Publicado: (2019) -
Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors
por: Moreo, Eduardo, et al.
Publicado: (2022) -
NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation
por: García-Cuesta, Eva María, et al.
Publicado: (2015)